Kadimastem Ltd (TLV:KDST)
3,100.00
+97.00 (3.23%)
Sep 16, 2025, 5:24 PM IDT
Kadimastem Market Cap
Kadimastem has a market cap or net worth of 125.94 million as of September 16, 2025. Its market cap has increased by 377.20% in one year.
Market Cap
125.94M
Enterprise Value
133.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3,100.00
Market Cap Chart
Since June 13, 2013, Kadimastem's market cap has increased from 72.88M to 125.94M, an increase of 72.80%. That is a compound annual growth rate of 4.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 15, 2025 | 125.94M | 134.24% |
Dec 31, 2024 | 53.76M | 116.19% |
Dec 31, 2023 | 24.87M | -37.96% |
Dec 29, 2022 | 40.08M | -66.07% |
Dec 30, 2021 | 118.12M | 197.88% |
Dec 31, 2020 | 39.65M | -27.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 76.30B |
Danel (Adir Yeoshua) | 2.90B |
Kamada | 1.35B |
SofWave Medical | 979.20M |
BrainsWay | 973.41M |
Bait Bakfar | 958.09M |
Novolog (Pharm-Up 1966) | 719.31M |
Ilex Medical | 708.32M |